Volume 85 Issue 21 | p. 16 | Concentrates
Issue Date: May 21, 2007

Lonza Reorganizes Microbial Production

Department: Business

Lonza is consolidating its U.S. microbial biopharmaceutical manufacturing activities at its Hopkinton, Mass., site, and phasing out operations in Baltimore by early 2008. The firm says Baltimore employees will be offered positions either in Hopkinton or at its Walkersville, Md., site. Hopkinton will become the global headquarters for Lonza's microbial biopharmaceuticals operations, and the Swiss firm will sink more than $30 million into the site to support its growth plans in microbial process development and manufacturing.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment